One specific example could be to use the oncolytic virus as a gene therapy vector to deliver small interfering RNA (siRNA) within the cancer cell, knocking down ADAM10 and ADAM17 expression, and thus prevent NKG2DL shedding. This evidence concerns the gene ADAM10 and cancer.